About this episode
Richard joins TWiV to discuss the SARS-CoV-2 antiviral drug Molnupiravir , including how it was discovered, its mechanism of action, whether it is a mutagen for cells, and the future of drugs for treatment of COVID-19.
Hosts: Vincent Racaniello, Alan Dove, and Brianne Barker
Guest: Richard Plemper
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Richard on TWiV 636
- Molnupiravir in ferrets (Nat Micro)
- Oral prodrug of Remdesivir in ferrets (Nat Commun)
- Letters read on TWiV 888
- Timestamps by Jolene. Thanks!
Weekly Picks
Brianne – BioRender Poster Builder
Alan – Hexbug cat toys
Vincent – US Mint 2019 American Innovation Coin – PA – Polio Vaccine
Listener Picks
Sue – American Visionary Art Museum
Frazer – Vaccine trial for killer elephant virus
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology